🚶♂️ The STRIDE trial tested semaglutide in patients with PAD and type 2 diabetes.
💉 Weekly injections for 52 weeks improved walking distance, pain-free mobility, and quality of life.
📊 Results showed significant gains vs placebo, with low adverse events.
🌟 Semaglutide may offer a new stride forward in treating functional limitations in PAD.
